Availability of Lyme Disease Vaccine

Overview

Journal MMWR Morb Mortal Wkly Rep

Date 1999 Feb 5

PMID 9933128

Citations 3

Affiliations

Soon will be listed here.

Abstract

On December 21, 1998, the Food and Drug Administration (FDA) licensed LYMErix (SmithKline Beecham Biologicals, Reixensart, Belgium), a new vaccine against Lyme disease (LD). This report summarizes information about this vaccine and provides epidemiologic information about LD relevant to vaccine use.

Citing Articles

Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model.

Huang C, Chen J, Shen K, Chang L, Yeh Y, Chen I PLoS One. 2012; 7(7):e40970.

PMID: 22815882 PMC: 3399806. DOI: 10.1371/journal.pone.0040970.

Surveillance of arthropod vector-borne infectious diseases using remote sensing techniques: a review.

Kalluri S, Gilruth P, Rogers D, Szczur M PLoS Pathog. 2007; 3(10):1361-71.

PMID: 17967056 PMC: 2042005. DOI: 10.1371/journal.ppat.0030116.

Strain typing of Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii by using multiple-locus variable-number tandem repeat analysis.

Farlow J, Postic D, Smith K, Jay Z, Baranton G, Keim P J Clin Microbiol. 2002; 40(12):4612-8.

PMID: 12454161 PMC: 154584. DOI: 10.1128/JCM.40.12.4612-4618.2002.